Medivir to present at the ABGSC Life Science Summit
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ABGSC Life Science Summit on May 18, 2022. The company will be represented by CEO Jens Lindberg.The presentation will be available after the meeting on Medivirs website; www.medivir.com. For additional information, please contact Magnus Christensen, CFO Telephone: +46 8 5468 3100 E-mail: magnus.christensen@medivir.com Medivir in brief Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates